// App-Quantinova.ai

OP0039 (2018) : High disease activity and disability at one year in two clusters of patients with rheumatoid arthritis defining themselves as in an acceptable state at treatment initiation

Researchers

Presenter

  • J. Gwinnutt

Principal Investigators

  • K. Hyrich

  • M. Lunt

  • A. Barton

  • S. Verstappen

Medical Centers

  • Arthritis Research UK Centre for Epidemiology, the University of Manchester

  • NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Central Nervous System (CNS)

Disease

  • Rheumatoid arthritis

  • Depression

  • Inflammatory Arthritis

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved